Tag Archive for: paes

Hansa Biopharma invite to Capital Markets Day 2026 in New York

/in

Lund, Sweden, June 12, 2026. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), is pleased to welcome investors and analysts to a Capital Markets Day on June 25, 2026. The Capital Markets Day will be held at The St. Regis Hotel, Two East 55th Street, at Fifth Avenue, New York, and will be broadcast live online. […]

Read more

Hansa Biopharma reports positive efficacy and safety results from Idefirix® European post authorization study in kidney transplantation

/in

The 1-year graft failure-free survival was 90%, which is clinically meaningful and supports full marketing authorization submission Idefirix was generally well tolerated with a safety profile consistent with previous clinical trial experience Submission to EMA for conversion to full marketing authorization planned for Q4 2026 Lund, Sweden, May 27, 2026. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: […]

Read more
© Optimum Strategic Communications.